<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Uzh on BEHIND-MS</title>
    <link>https://www.behind-ms.eu/en/tags/uzh/</link>
    <description>Recent content in Uzh on BEHIND-MS</description>
    <generator>Hugo</generator>
    <language>en</language>
    <lastBuildDate>Sun, 12 May 2024 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.behind-ms.eu/en/tags/uzh/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Clinical Neuroimmuology – Multiple Sclerosis Centre of Catalonia</title>
      <link>https://www.behind-ms.eu/en/teams/vhir/</link>
      <pubDate>Sun, 12 May 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/teams/vhir/</guid>
      <description>&lt;p&gt;&lt;img src=&#34;https://www.behind-ms.eu/img/teams/vhir-pic.jpg&#34; alt=&#34;VHIR&#34;&gt;&lt;/p&gt;&#xA;&lt;h2 id=&#34;contribution-to-the-project&#34;&gt;Contribution to the project:&lt;/h2&gt;&#xA;&lt;p&gt;VHIR will recruit 20 treatment-naïve patients with relapsing-remitting (N=18) and primary progressive (N=2) MS who produce EBV in throat washes, and 20 sex/age-matched controls. Blood samples and throat washes will be sent to several consortium partners. VHIR will also investigate the interactions between EBV and cytomegalovirus by performing single-cell RNA sequencing in peripheral blood cells from MS patients at the time of the first demyelinating event.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Institute of Experimental Immunology, University of Zurich</title>
      <link>https://www.behind-ms.eu/en/teams/uzh/</link>
      <pubDate>Sun, 12 May 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/teams/uzh/</guid>
      <description>&lt;h2 id=&#34;contribution-to-the-project&#34;&gt;Contribution to the project&lt;/h2&gt;&#xA;&lt;p&gt;Mice with reconstituted human immune systems (Humanized Mice) are used to model EBV infection and how it influences CNS infiltration as well as neuroaxonal damage, prodromal signs of MS.&lt;/p&gt;&#xA;&lt;h2 id=&#34;team-members&#34;&gt;Team Members&lt;/h2&gt;&#xA;&lt;p&gt;&lt;img src=&#34;https://www.behind-ms.eu/img/teams/UZH-team.jpg&#34; alt=&#34;UZH Team&#34;&gt;&lt;/p&gt;&#xA;&lt;h3 id=&#34;christian-münz-phd--professor-and-co-director-of-the-institute-of-experimental-immunology&#34;&gt;Christian Münz, PhD – Professor and Co-Director of the Institute of Experimental Immunology&lt;/h3&gt;&#xA;&lt;p&gt;Christian Münz has been trained in immunology at the German Cancer Research Institute in Heidelberg, Germany, the University of Tübingen, Germany, and the Rockefeller University in New York, USA. He became Assistant Professor and Head of Laboratory at the Rockefeller University in 2003. In 2008 he was recruited as Associate Professor and Co-Director of the Institute of Experimental Immunology to the University of Zürich, Switzerland, and became Full Professor in 2015. Since 2010 he is also Visiting Professor at the Imperial College in London, UK. In 2006 he received the Burroughs Welcome Fund Investigators in Pathogenesis of Infectious Disease Award for his studies on antigen processing via macroautophagy, and in 2012 the Sobek Award for his studies on the association of Epstein Barr virus (EBV) infection with multiple sclerosis (MS). He is an expert in EBV specific immune control and humanized mice as preclinical models for human oncogenic gamma-herpesvirus infections, and has published more than 300 peer reviewed papers and review articles on these topics.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
